Study details
Enrolling now
Study of Psilocybin for Anorexia in Young Adults
Marissa Raymond-Flesch, MD, MPH
NCT IDNCT06399263ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
40
Study length
about 5 years
Ages
18–25
Locations
2 sites in CA
About this study
This trial is testing a treatment using psilocybin to help young adults with anorexia nervosa. The treatment includes preparation and integration sessions, along with the psilocybin medication itself. Eating disorder symptoms will be measured before and after the treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Preparation and Integration Sessions
- 2.Take Psilocybin
PhasePhase 2
DrugPsilocybin
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
oral
Body systems
Psychiatry / Mental Health